Filtered By:
Condition: Low Testosterone
This page shows you your search results in order of relevance. This is page number 6.
Order by Relevance | Date
Total 113 results found since Jan 2013.
Endocrine manifestations and new developments in mitochondrial disease
Endocr Rev. 2021 Oct 13:bnab036. doi: 10.1210/endrev/bnab036. Online ahead of print.ABSTRACTMitochondrial diseases are a group of common inherited diseases causing disruption of oxidative phosphorylation. Some patients with mitochondrial disease have endocrine manifestations, with diabetes being predominant but also include hypogonadism, hypoadrenalism and hypoparathyroidism. There have been major developments in mitochondrial disease over the last decade that have major implications for all patients. The collection of large cohorts of patients has better defined the phenotype of mitochondrial diseases and the majority of ...
Source: ENDOCR REV - October 13, 2021 Category: Endocrinology Authors: Yi Shiau Ng Albert Zishen Lim Grigorios Panagiotou Doug M Turnbull Mark Walker Source Type: research
Role of sex hormones in modulating myocardial perfusion and coronary flow reserve
ConclusionOur experimental data in mice indicate that sex differences in myocardial perfusion are primarily driven by testosterone. Given the diagnostic importance of PET-MPI in clinical routine, further studies are warranted to determine whether testosterone levels affect the interpretation of myocardial perfusion findings in patients.
Source: European Journal of Nuclear Medicine and Molecular Imaging - January 13, 2022 Category: Nuclear Medicine Source Type: research
Endocrine Manifestations and New Developments in Mitochondrial Disease
Endocr Rev. 2022 May 12;43(3):583-609. doi: 10.1210/endrev/bnab036.ABSTRACTMitochondrial diseases are a group of common inherited diseases causing disruption of oxidative phosphorylation. Some patients with mitochondrial disease have endocrine manifestations, with diabetes mellitus being predominant but also include hypogonadism, hypoadrenalism, and hypoparathyroidism. There have been major developments in mitochondrial disease over the past decade that have major implications for all patients. The collection of large cohorts of patients has better defined the phenotype of mitochondrial diseases and the majority of patient...
Source: Endocrine Reviews - May 13, 2022 Category: Endocrinology Authors: Yi Shiau Ng Albert Zishen Lim Grigorios Panagiotou Doug M Turnbull Mark Walker Source Type: research
